27.32 USD
▲+0.42+1.54%
盘后 27.21 -0.38%
2026-11-19
市值
$1.36B
市盈率
—
EPS
-1.20
股息率
—
52 周区间
19.14 – 57.14
成交量
178.00K
Beta
0.54
目标价
53.35
52W 低 19.1452W 高 57.14
价格走势
公司简介
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Th...